Comparing the lasting effects: post COVID vs. non-COVID acute respiratory infections

Kyowa will pay $16.00 per American Depositary Share (ADS) in cash for Orchard, totalling about ¥57.3bn ($387.4m). Image Credit: vchal / Shutterstock. The Japan-based pharmaceutical

In a land­mark mo­ment for ge­net­ic med­i­cine and sick­le cell dis­ease pa­tients, the FDA on Fri­day ap­proved not just one but two gene ther­a­pies for